| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
18,394 |
17,152 |
$2.04M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,728 |
7,548 |
$983K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
6,279 |
5,691 |
$695K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
8,796 |
6,759 |
$648K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,470 |
2,015 |
$579K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,236 |
3,863 |
$527K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,723 |
6,543 |
$477K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,048 |
4,632 |
$430K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,866 |
1,451 |
$369K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,417 |
2,193 |
$293K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
2,783 |
789 |
$236K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,919 |
639 |
$153K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
549 |
410 |
$137K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,404 |
925 |
$128K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
446 |
273 |
$104K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
521 |
271 |
$93K |
| G0378 |
Hospital observation service, per hour |
3,093 |
1,039 |
$87K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,163 |
815 |
$82K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
12,609 |
9,785 |
$67K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,137 |
870 |
$58K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
256 |
212 |
$54K |
| 80053 |
Comprehensive metabolic panel |
9,318 |
7,354 |
$52K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
252 |
218 |
$50K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
251 |
170 |
$49K |
| 20611 |
|
131 |
119 |
$37K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
582 |
474 |
$37K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,356 |
1,255 |
$37K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
355 |
297 |
$37K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,517 |
2,067 |
$37K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
132 |
124 |
$35K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
22,400 |
17,378 |
$35K |
| 71250 |
|
463 |
366 |
$35K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,417 |
1,151 |
$31K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,728 |
7,015 |
$24K |
| 84484 |
|
7,619 |
5,368 |
$20K |
| 36415 |
Collection of venous blood by venipuncture |
27,690 |
20,317 |
$20K |
| 71045 |
Radiologic examination, chest; single view |
7,725 |
6,374 |
$20K |
| 71046 |
Radiologic examination, chest; 2 views |
705 |
595 |
$17K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,014 |
2,849 |
$15K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,739 |
1,440 |
$14K |
| 80061 |
Lipid panel |
1,842 |
1,562 |
$14K |
| 94060 |
|
102 |
90 |
$13K |
| Q3014 |
Telehealth originating site facility fee |
1,144 |
1,027 |
$11K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,478 |
2,044 |
$11K |
| 73630 |
|
434 |
345 |
$10K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
643 |
556 |
$10K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
141 |
58 |
$10K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
234 |
186 |
$8K |
| 90686 |
|
764 |
642 |
$7K |
| 64493 |
|
14 |
12 |
$7K |
| J3490 |
Unclassified drugs |
1,065 |
634 |
$6K |
| 80076 |
|
1,986 |
1,814 |
$6K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,634 |
1,440 |
$6K |
| 62323 |
|
12 |
12 |
$6K |
| 73562 |
|
109 |
100 |
$6K |
| 73610 |
|
272 |
216 |
$5K |
| 83880 |
|
2,136 |
1,574 |
$5K |
| 81001 |
|
7,775 |
6,487 |
$5K |
| 72020 |
|
705 |
658 |
$5K |
| 73130 |
|
282 |
232 |
$4K |
| 85610 |
|
4,778 |
3,772 |
$4K |
| 82607 |
|
380 |
334 |
$4K |
| 73030 |
|
202 |
161 |
$4K |
| 87088 |
|
2,319 |
1,706 |
$4K |
| 83605 |
|
3,379 |
2,341 |
$4K |
| 87040 |
|
2,728 |
1,204 |
$4K |
| 72100 |
|
141 |
117 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
865 |
728 |
$4K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,095 |
3,216 |
$4K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
15 |
12 |
$3K |
| 83735 |
|
2,795 |
1,909 |
$3K |
| 85027 |
|
877 |
462 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,948 |
1,364 |
$3K |
| 94729 |
|
41 |
40 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,656 |
1,744 |
$3K |
| 11721 |
|
126 |
122 |
$3K |
| 94726 |
|
49 |
41 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,331 |
734 |
$3K |
| 83540 |
|
426 |
357 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,624 |
1,487 |
$2K |
| 82947 |
|
1,551 |
466 |
$2K |
| 85730 |
|
3,164 |
2,586 |
$2K |
| 11719 |
|
165 |
159 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,602 |
1,384 |
$2K |
| 85379 |
|
1,506 |
1,237 |
$2K |
| 84703 |
|
1,370 |
1,060 |
$2K |
| 82077 |
|
866 |
647 |
$2K |
| 82948 |
|
2,033 |
806 |
$2K |
| 96367 |
|
84 |
54 |
$2K |
| 82248 |
|
2,019 |
1,518 |
$2K |
| 83690 |
|
2,603 |
1,999 |
$1K |
| 90715 |
|
104 |
88 |
$1K |
| 82803 |
|
1,172 |
682 |
$1K |
| 82565 |
|
147 |
117 |
$1K |
| 82140 |
|
418 |
300 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
726 |
611 |
$1K |
| 81003 |
|
1,559 |
1,267 |
$1K |
| 96376 |
|
715 |
355 |
$1K |
| 73560 |
|
118 |
92 |
$1K |
| 80143 |
|
498 |
376 |
$1K |
| 76536 |
|
12 |
12 |
$962.38 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
987 |
671 |
$877.25 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,319 |
1,807 |
$851.25 |
| 80179 |
|
473 |
363 |
$851.00 |
| 86140 |
|
123 |
66 |
$746.70 |
| 97162 |
|
16 |
14 |
$712.11 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,564 |
1,000 |
$671.62 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
89 |
50 |
$628.03 |
| 82550 |
|
384 |
281 |
$610.37 |
| 82570 |
|
92 |
72 |
$589.60 |
| 73502 |
|
36 |
27 |
$532.11 |
| 87186 |
|
815 |
502 |
$502.06 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
44 |
40 |
$481.89 |
| 94761 |
|
786 |
620 |
$478.28 |
| 83525 |
|
84 |
57 |
$460.38 |
| 90656 |
|
56 |
49 |
$434.07 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1,020 |
864 |
$432.72 |
| 73590 |
|
18 |
12 |
$411.36 |
| 82150 |
|
837 |
689 |
$401.04 |
| 87420 |
|
216 |
186 |
$400.89 |
| 87081 |
|
115 |
95 |
$344.93 |
| 82962 |
|
822 |
656 |
$323.69 |
| 74018 |
|
19 |
15 |
$312.29 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
780 |
417 |
$272.77 |
| 94760 |
|
437 |
351 |
$261.09 |
| 84100 |
|
225 |
196 |
$239.04 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
215 |
147 |
$229.85 |
| 85652 |
|
92 |
58 |
$217.94 |
| 84439 |
|
15 |
12 |
$216.93 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
14 |
12 |
$199.64 |
| 84466 |
|
56 |
47 |
$178.35 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
423 |
247 |
$164.56 |
| 73110 |
|
12 |
12 |
$133.08 |
| 87280 |
|
78 |
60 |
$129.86 |
| 81025 |
|
169 |
162 |
$125.86 |
| 82728 |
|
57 |
47 |
$122.39 |
| 87400 |
|
125 |
114 |
$116.06 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
26 |
26 |
$113.24 |
| 87077 |
|
43 |
33 |
$87.04 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
389 |
278 |
$83.34 |
| 80320 |
|
13 |
13 |
$82.52 |
| 84156 |
|
15 |
12 |
$71.70 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
128 |
102 |
$71.28 |
| 74022 |
|
41 |
38 |
$69.44 |
| 87581 |
|
14 |
12 |
$67.10 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
52 |
51 |
$65.06 |
| 36600 |
|
128 |
62 |
$64.73 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
129 |
61 |
$55.92 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
38 |
18 |
$55.26 |
| 82746 |
|
48 |
42 |
$54.25 |
| 87430 |
|
59 |
57 |
$49.74 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
209 |
168 |
$47.40 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
336 |
241 |
$44.00 |
| 87486 |
|
14 |
12 |
$33.55 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
14 |
12 |
$33.55 |
| 51702 |
|
14 |
12 |
$29.20 |
| 90732 |
|
13 |
13 |
$27.30 |
| J2060 |
Injection, lorazepam, 2 mg |
132 |
87 |
$19.87 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
266 |
169 |
$16.77 |
| C9113 |
Injection, pantoprazole sodium, per vial |
19 |
12 |
$16.51 |
| J7050 |
Infusion, normal saline solution, 250 cc |
167 |
102 |
$13.71 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
186 |
107 |
$12.42 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
615 |
415 |
$11.70 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
53 |
48 |
$11.56 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
14 |
14 |
$8.40 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
24 |
12 |
$7.75 |
| 84132 |
|
39 |
12 |
$6.35 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
33 |
14 |
$2.49 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
14 |
12 |
$2.40 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
67 |
26 |
$2.17 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
14 |
12 |
$0.91 |
| 64494 |
|
14 |
12 |
$0.00 |
| J0456 |
Injection, azithromycin, 500 mg |
14 |
12 |
$0.00 |
| A9270 |
Non-covered item or service |
1,027 |
47 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
313 |
230 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
79 |
68 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
28 |
23 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
17 |
12 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
29 |
12 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
554 |
311 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
42 |
41 |
$0.00 |
| 99218 |
|
47 |
15 |
$0.00 |